| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.5M | +55.0% |
| R&D Expense | $301K | -49.1% |
| SG&A Expense | $9.6M | +8.7% |
| Operating Income | -$7.8M | +4.5% |
| Interest Expense | $500K | -0.0% |
| Net Income | -$8.2M | +3.7% |
| EPS (Basic) | -$2.62 | +17.6% |
| EPS (Diluted) | -$2.62 | +17.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.8M | +7.6% |
| Accounts Receivable | $625K | +111.7% |
| Inventory | $289K | +56.0% |
| Current Assets | $11.7M | +11.0% |
| Total Assets | $11.9M | +12.1% |
| Current Liabilities | $1.7M | +17.7% |
| Total Liabilities | $7.8M | +10.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.6M | +46.6% |
| Financing Cash Flow | $7.3M | -45.7% |
| Stockholders' Equity |
| $4.1M |
| +14.9% |